Commercializing Rare Disease Treatment With Near Real-Time Physician Alerts

Identifying patients with rare blood disorders in a timely manner is critical to improving outcomes and enabling access to potentially life-saving therapies. A leading pharmaceutical company partnered with Quest Diagnostics to overcome the data latency challenges associated with traditional EHR and claims data by leveraging near real-time laboratory data. This collaboration focused on a rare, life-threatening blood disorder.

Quest provided daily Commercial Alerts based on test orders and results, enabling the pharmaceutical company’s sales team to identify physicians treating patients with relevant diagnostic markers. Lab data—available within days—offered actionable insights during the narrow treatment window, improving the speed and accuracy of diagnosis and therapeutic decision-making. This case highlights the critical role of lab data in accelerating orphan drug adoption, enabling earlier intervention, and ultimately expanding access to treatment for rare blood disorder patients.